Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2006
The purpose of this study was to evaluate the effect of treatment with epoetin alfa (recombinant human erythropoietin) or placebo on anemia related quality-of-life and anemia in hormone-refractory (not responding to hormone therapy) prostate cancer patients.
Epistemonikos ID: af10d1b055f2c24d89b7c188b0e5cadea56b02ed
First added on: Dec 01, 2021